Sanofi
- Targets
- 10
- Filings
- 16
- Median premium
- 80%
- First filing
- Feb 7, 2018
- Latest filing
- Feb 10, 2026
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | 4 / 7 | — | 3 | Feb 10, 2026 |
| Vigil Neuroscience, Inc. | — | — | 3 | Jun 30, 2025 |
| Blueprint Medicines Corp | 1 / 7 | — | 2 | Jun 17, 2025 |
| Provention Bio, Inc. | — | — | 1 | Mar 24, 2023 |
| Kadmon Holdings, Inc. | — | — | 2 | Oct 4, 2021 |
| Translate Bio, Inc. | 2 / 7 | — | 1 | Aug 16, 2021 |
| Principia Biopharma Inc. | 2 / 7 | — | 1 | Aug 28, 2020 |
| Synthorx, Inc. | — | — | 1 | Dec 23, 2019 |
| Ablynx NV | — | — | 1 | Apr 4, 2018 |
| Bioverativ Inc. | — | — | 1 | Feb 7, 2018 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Feb 10, 2026 | DYNAVAX TECHNOLOGIES CORP | 8-K | — | — |
| Jan 12, 2026 | DYNAVAX TECHNOLOGIES CORP | SC TO-T | — | — |
| Dec 29, 2025 | DYNAVAX TECHNOLOGIES CORP | 8-K | — | — |
| Jun 30, 2025 | Vigil Neuroscience, Inc. | DEFM14A | $8.00 | 80% |
| Jun 17, 2025 | Blueprint Medicines Corp | SC TO-T | — | — |
| Jun 16, 2025 | Vigil Neuroscience, Inc. | PREM14A | $8.00 | 80% |
| Jun 2, 2025 | Blueprint Medicines Corp | 8-K | — | — |
| May 22, 2025 | Vigil Neuroscience, Inc. | 8-K | — | — |
| Mar 24, 2023 | Provention Bio, Inc. | SC TO-T | — | — |
| Oct 4, 2021 | Kadmon Holdings, Inc. | DEFM14A | $9.50 | 79% |
| Sep 21, 2021 | Kadmon Holdings, Inc. | PREM14A | $9.50 | 79% |
| Aug 16, 2021 | Translate Bio, Inc. | SC TO-T | — | — |
| Aug 28, 2020 | Principia Biopharma Inc. | SC TO-T | — | — |
| Dec 23, 2019 | Synthorx, Inc. | SC TO-T | — | — |
| Apr 4, 2018 | Ablynx NV | SC TO-T | — | — |
| Feb 7, 2018 | Bioverativ Inc. | SC TO-T | — | — |